ARCHIVES

Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

September 27, 2013

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

In Brief: Muggia Leaving NCI For NYU In September; Seminar Planned On radiation Exposures

April 20, 1979

IOM Report Says Smoking Bans Cut Heart Attack Risk

October 23, 2009

Carcinogenesis Testing Moved Out of DCCP To New Status As Division, Giving Rall More Authority

September 14, 1979